ME Therapeutics Holding (XCNQ:METX) Accounts Payable & Accrued Expense : C$0.00 Mil (As of Feb. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Accounts Payable & Accrued Expense?

ME Therapeutics Holding's quarterly accounts payable & accrued expense declined from Aug. 2023 (C$0.11 Mil) to Nov. 2023 (C$0.04 Mil) and declined from Nov. 2023 (C$0.04 Mil) to Feb. 2024 (C$0.00 Mil).

ME Therapeutics Holding's annual accounts payable & accrued expense increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$0.04 Mil) and increased from Aug. 2022 (C$0.04 Mil) to Aug. 2023 (C$0.11 Mil).

ME Therapeutics Holding Accounts Payable & Accrued Expense Historical Data

The historical data trend for ME Therapeutics Holding's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Accounts Payable & Accrued Expense Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

Accounts Payable & Accrued Expense

0.04

0.11

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			0.13	0.08	0.11	0.04	-

ME Therapeutics Holding Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

Q9T:Germany

Address

177 Robson Street, Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines